Dupilumab in HIV-positive patients: A case series report of 4 patients
- PMID: 33304976
- PMCID: PMC7718127
- DOI: 10.1016/j.jdcr.2020.09.023
Dupilumab in HIV-positive patients: A case series report of 4 patients
Keywords: AD, atopic dermatitis; BSA, body surface area; HAART, highly active antiretroviral therapy; HIV; IGA, investigator global assessment; TH2, helper T cell type 2; atopic dermatitis; biologics; dupilumab.
Figures
References
-
- Mollanazar N., Qiu C., Aldrich J. Use of dupilumab in patients who are HIV-positive: report of four cases. Br J Dermatol. 2019;181(6):1311–1312. - PubMed
-
- Yechiel B. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers - A review and hypothesis. Virus Genes. 2004;28(1):5–18. - PubMed
-
- Rudikoff D. The relationship between HIV infection and atopic dermatitis. Curr Allergy Asthma Rep. 2002;2(4):275–281. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous